The Microbe Discovery Project

A patient-led initiative supporting Dr. Ian Lipkin & Dr. Mady Hornig's ME/CFS research
at the Columbia University Center for Infection and Immunity, Mailman School of Public Health, New York.

New Research Discovers Evidence of Atypical & Classical ME/CFS

New Research Discovers Evidence of Atypical & Classical ME/CFS

This latest research is the first to report evidence differentiating Atypical and Classical ME/CFS The researchers measured 51 different cytokines (immune messenger molecules) in cerebrospinal fluid. Their immune network analysis of these cytokines provided evidence that Atypical and Classical cases of ME/CFS have differing immune signatures within the central nervous system. This work suggests distinct presentations and course of diseaseRead more about New Research Discovers Evidence of Atypical & Classical ME/CFS[…]

The ME/CFS Biomarker Rollercoaster

The ME/CFS Biomarker Rollercoaster

    Biomarkers are a holy grail for ME/CFS because they have the potential to help diagnose disease, track disease progression or progress and help inform which treatments might help. The need for biomarkers is immense and researchers will identify many possible ones. It is encouraging that there have been more possible biomarker reports recently. It canRead more about The ME/CFS Biomarker Rollercoaster[…]